---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-000587"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2025-03-25T23:59:59+00:00"
generated_at: "2026-05-24T06:16:04.543028+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aspira Women’s Health VP of Finance James Crawford resigns effective April 4, 2025

## Summary
- James Crawford informed CEO Mike Buhle of his resignation as VP of Finance on March 21, 2025.
- Resignation is for personal reasons and effective April 4, 2025.
- No replacement has been announced as of the filing date.

## SEC filing metadata
- accession: 0001641172-25-000587
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2025-03-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000164117225000587/0001641172-25-000587-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000164117225000587/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-000587
- JSON: https://secwatch.observer/filing/0001641172-25-000587.json
- Plain text: https://secwatch.observer/filing/0001641172-25-000587.txt

## Key facts
- Executive change
  James Crawford resigned as VP of Finance at Aspira Women's Health Inc..
  - Action: resigned
  - Role: VP of Finance
  source text: On March 21, 2025, James Crawford informed Mike Buhle, the Chief Executive Officer of Aspira Women’s Health Inc. (the “Company”) that he was resigning as VP of Finance of the Company, for personal reasons, effective April 4, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000164117225000587/0001641172-25-000587-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.